Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-883-3 | CAS number: 3648-18-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
![](https://echa.europa.eu./o/diss-blank-theme/images/factsheets/A-REACH/factsheet/print_toxicological-information.png)
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 1
- Absorption rate - inhalation (%):
- 100
Additional information
In accordance with point 8.8.1 of column 1 (Standard Information Required), Annex VIII of REACH (Regulation EC No. 1907/2006), assessment of the toxicokinetic behaviour of the substance is performed to the extent that can be derived from the relevant available information. A toxicokinetic assessment was performed based on the available physical-chemical data and toxicological information available. Further testing for the assessment of toxicokinetic behaviour is omitted on this basis.
Introduction
Physico-chemical properties and the results of in vitro studies and in vivo acute and repeat dose toxicity studies for dioctyltin dilaurate (DOTL – CAS No. 3648-18-8) have been used to determine a toxicokinetic profile.
Physicochemical properties
DOTL is a colourless liquid and has the molecular formula C40H80O4Sn with a molecular weight of 743.8 g/mol. It is very sparingly water soluble (0.0000152 g/L at 20°C). DOTL was determined to be hydrolytically unstable at pH 4, 7 and 9, with a half life of less than 4.5 hours. The test material was observed to immediately hydrolyse to dioctyltin oxide (DOTO) and lauric acid in the presence of water. Based on these findings, testing for a partition coefficient was alsonot technically possible.
Absorption
Oral absorption
In an in vitro study simulating gastric conditions to determine the extent of hydrolysis to DOTL, no meaningful results were obtained, because DOTL isimmediately hydrolysed to DOTO (insoluble) and lauric acid in the presence of water. Therefore no reaction rate constants or half life values could be calculated. Based on the results obtained it could be concluded that the half life of the test material is below 4.5 hours.It was noted that the transformation rate was slightly elevated in acidic conditions but not to any significant levels. DOTL appears to rapidly hydrolyse under simulated gastricconditions.
As DOTL is anticipated tobe immediately hydrolysed to DOTO and lauric acid in the gut, it can be considered that the absorption of DOTL would be equivalent to that of its hydrolysed components. In a similar study conducted with DOTO the percentage of hydrolysis never exceeded 55% and in most cases was considerably lower (2 – 5%); it was concluded that DOTO would not hydrolyse to an appreciable extent under gastric conditions. DOTO appeared to be relatively resistant to the simulated gastric hydrolysis.
Lauric acid is a 12-carbon medium chain fatty acids. As a component of triglycerides lauric acid is naturally occurring in the body and in the diet. It is also available for use in food and feed supplements and used as a therapeutic agent for a range of conditions, there is a vast amount of published medical papers. Lauric acid, comprises about half of the fatty acid content in coconut oil, laurel oil, and in palm kernel oil; it is also found in human breast milk, cow's milk, and goat's milk. As a result lauric acid is considered to be readily absorbed following the fatty acid metabolic pathway and non-toxic.
With respect to DOTO the available information on acute oral toxicity supports a limited oral absorption, as the reported LD50 values are generally higher than a limit dose of 2000 mg/kg bw (up to greater than 6000 mg/kg bw). Some oral absorption is also demonstrated by results of a fully compliant OECD 422 study, using the dietary route of exposure, because treatment at a dietary level equivalent to 1.5-2.4 mg/kg/day resulted in adverse effects on thymus; at a higher dietary concentration (equivalent to 11-17 mg/kg/day) treatment also affected reproductive parameters, and some signs of liver involvement were also noted.
As a worst-case estimate, for risk assessment purposes DOTL is considered to be absorbed at 50 % or less following oral administration. For risk assessment purposes 50 % is assumed.
Dermal absorption
No information is available on dermal absorption. DOTL is a liquid with a large MW of 743.8 g/mol and is poorly soluble in water (0.0000152 g/L at 20 °C). Given its poor solubility,it will associate with itself and will not easily diffuse across lipid bilayers, or penertrate the stratum corneum (its large size will limit it transmission through the lipid filled channels between dead cells in the stratum corneum). These factors indicate the rate of transfer from the stratum corneum and the epidermis will be slow, and will limit absorption across the skin. As such a value of 1% for dermal absorption is considered a very conservative estimate.
Inhalation absorption
No information is available on inhalation toxicity of the substance, or on inhalation absorption. The vapour pressure of the test material was determined in accordance with standardised guidelines at temperatures of 20, 25 and 50 °C and calculated to be 0.0015, 0.0022 and 0.011 Pa, respectively. Based on the results of this study DOTL is considered to have a low vapour pressure.
As a worst case and really conservative approach, the inhalation absorption in humans is considered to be complete (100 %) for risk assessment purposes.
Distribution
Results of the OECD 422 study suggest that, once hydrolysed and absorbed as DOTO, the material is widely distributed within the body, as the target organ was the thymus and, at higher doses, the reproductive system and the liver. Given the high estimated log Pow and the extremely low water solubility of DOTO, micellular solubilisation may play a major role for absorption, and preferential partition to tissues with high lipid content.
Metabolism
No information is available. Given the results of submitted hydrolysis study (Lange, 2012a) and the resultant formation of DOTO no significant biotransformation anticipated to occur.
Lauric acid would be expected to follow the fatty acid metabolism pathway following dissociations from DOTL.
Elimination
Once hydrolysed and absorbed as DOTO,unchanged DOTO is expected to be excreted mainly via the faeces.
A bioaccumulation study in fish with a structurally related substance determined a BCF of >100. No upper limit appears to have been verified hence it is not possible to estimate the extent of elimination of the material from fatty tissues.
Conclusion
For risk assessment purposes, moderate absorption following oral administration is assumed (50 %) for DOTL, but it is estimated to be less absorbed following dermal exposure (1 %), and completely absorbed following inhalation (100 %).
The substance is considered to be immediately hydrolysed to DOTO and lauric acid in the gut,widely distributed within the body, hardly metabolised, and excreted mainly as unchanged DOTO in the faeces.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
![ECHA](/o/diss-blank-theme/images/factsheets/A-REACH/factsheet/echa_logo.png)